🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

16+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 16 recruiting trials for “Primary sclerosing cholangitis

Phase 1RecruitingNCT07229911

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

👨‍⚕️ Study Director, Takeda📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT06699121

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

🏥 LISCure Biosciences📍 7 sites📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06905054

Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

👨‍⚕️ Channa Jayasekera, Mayo Clinic📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06865924

Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06297993

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

👨‍⚕️ Cynthia Levy, MD, University of Miami📍 16 sites📅 Started May 2024View details ↗
NARecruitingNCT06351696

The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

👨‍⚕️ Azita Hekmatdoost, MD, PhD, Shahid Beheshti University of Medical Sciences📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06286709

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

🏥 University of Birmingham📍 5 sites📅 Started Mar 2024View details ↗
EARLY_Phase 1RecruitingNCT06197308

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

👨‍⚕️ Elizabeth Aby, University of Minnesota📍 1 site📅 Started Mar 2024View details ↗
Phase 2RecruitingNCT05835505

Detoxification of the Liver In PSC (Dolphin)

👨‍⚕️ Joshua A Korzenik, MD, Brigham and Womens Hospital📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05876182

Vancomycin in Primary Sclerosing Cholangitis in Italy

🏥 University of Milano Bicocca📍 1 site📅 Started Jun 2023View details ↗
EARLY_Phase 1RecruitingNCT05912387

Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

👨‍⚕️ Sidhartha Sinha, MD, Stanford University📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05295680

Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.

👨‍⚕️ Aparna Goel, MD, Stanford University📍 2 sites📅 Started May 2023View details ↗
RecruitingNCT04685200

Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

👨‍⚕️ Theo Heller, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Mar 2023View details ↗
RecruitingNCT05618145

National Database on Primary Sclerosing Cholangitis (PSC)

🏥 University of Milano Bicocca📍 63 sites📅 Started Oct 2022View details ↗
RecruitingNCT04181138

Primary Sclerosing Cholangitis in Children

👨‍⚕️ Cara Mack, MD, Medical College of Wisconsin-Milwaukee📍 12 sites📅 Started Dec 2021View details ↗
RecruitingNCT03146936

Swiss Primary Sclerosing Cholangitis Cohort Study

🏥 Fondazione Epatocentro Ticino📍 21 sites📅 Started Feb 2017View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →